Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

20
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
20
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimum Patient's Selection for Atrial Fibrillation Ablation Using Echocardiography.

Diagnostics (Basel, Switzerland)·2025
Same author

Haemostatic changes and outcomes in transcatheter aortic valve implantation.

Acta cardiologica·2025
Same author

Blood biomarkers in left-sided valvular heart disease.

European heart journal·2025
Same author

The Role of Trans-Oesophageal Echocardiography in the Interventional Cardiology of Adult Congenital Heart Diseases.

Journal of clinical medicine·2025
Same author

About a "false-positive" case of elevated troponin levels: differential diagnosis.

Acta cardiologica·2025
Same author

Echocardiography in the Ventilated Patient: What the Clinician Has to Know.

Journal of clinical medicine·2025
Same journal

Evidence-Based Clinical Recommendations for the Appropriate Use of Diagnostic Tests in Pediatric Allergology: Focus on Asthma, Rhinoconjunctivitis, and Keratoconjunctivitis Vernal.

Journal of clinical medicine·2026
Same journal

Surgical and Transcatheter Approach of a Failed Mitral Valve Repair: A Comprehensive Review on Selecting the Most Suitable Approach.

Journal of clinical medicine·2026
Same journal

Hybrid Metaheuristic Feature Selection for Breast Cancer Detection in Digital Mammography: A Feasibility Study with Nested Validation, Benchmarking, and External Stress Testing.

Journal of clinical medicine·2026
Same journal

Identity Transformation and the Role of Accountability in Recovery from Problematic Pornography Use: A Phenomenological-Hermeneutical Study.

Journal of clinical medicine·2026
Same journal

Does Early Surgical Treatment in Degenerative Cervical Myelopathy Have a Favorable Clinical Outcome and Impact on Quality of Life?

Journal of clinical medicine·2026
Same journal

Shear Wave Elastography in Musculoskeletal Imaging: A Narrative Review.

Journal of clinical medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 16, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.6K

TAVI after More Than 20 Years.

Adriana Postolache1, Simona Sperlongano2, Patrizio Lancellotti1

  • 1Cardiology Department, GIGA Cardiovascular Sciences, University of Liège Hospital, CHU Sart Tilman, 4000 Liège, Belgium.

Journal of Clinical Medicine
|September 9, 2023
PubMed
Summary
This summary is machine-generated.

Transcatheter aortic valve intervention (TAVI) has evolved significantly over 20 years, expanding patient eligibility and reducing complications. This review covers TAVI patient evaluation, procedural changes, and current challenges.

Keywords:
TAVIaortic stenosis

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

379

Related Experiment Videos

Last Updated: Jul 16, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.6K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

379

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Transcatheter aortic valve intervention (TAVI) has undergone significant advancements since its inception over two decades ago.
  • Initially developed for non-operable patients, TAVI is now indicated for a broader spectrum of patients, including those at low surgical risk.
  • The technique has demonstrated a notable reduction in complication rates over time.

Purpose of the Study:

  • To provide a comprehensive review of transcatheter aortic valve intervention (TAVI).
  • To discuss the evolution of TAVI procedures and patient selection criteria.
  • To outline current complications and challenges associated with TAVI.

Main Methods:

  • Review of existing literature and clinical data on TAVI.
  • Analysis of procedural modifications and technological advancements in TAVI.
  • Examination of patient outcomes and complication rates in TAVI.

Main Results:

  • TAVI's application has expanded from inoperable to low-risk patients with aortic stenosis.
  • Significant improvements in TAVI technique have led to decreased complication incidence.
  • The review details patient evaluation, procedural evolution, and current TAVI challenges.

Conclusions:

  • TAVI represents a major advancement in treating aortic stenosis, offering a less invasive option.
  • Continued evolution of TAVI technology and patient selection is crucial for optimizing outcomes.
  • Addressing current complications and challenges will further enhance TAVI's role in cardiovascular care.